Last updated on April 2018

C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

Brief description of study

This is a non-interventional treatment Registry of Hereditary Angioedema (HAE) patients treated with C1 inhibitor, either plasma-derived (pdC1INH) or the recombinant human form (Ruconest), to observe adverse events and insufficient efficacy, and to assess the immunological profile following single and repeated treatment with Ruconest.

Detailed Study Description

see below

Clinical Study Identifier: NCT01397864

Contact Investigators or Research Sites near you

Start Over

Maria Staevska, Prof.

UMHAT Alexandrovska EAD
Sofia, Bulgaria
  Connect »

Roman Hakl, Dr.

Faculty Hospital by St. Anna Brno
Brno, Czech Republic
  Connect »

Laurence Bouillet, Prof. Dr.

Hospital A Michallon, CHU Grenoble
La Tronche, France
  Connect »

Marcus Maurer, Prof.

Charite Universitatsmedizin Berlin
Berlin, Germany
  Connect »

Henriette Farkas, Prof.

Semmelweis University, 3rd Department of Internal Medicine
Budapest, Hungary
  Connect »

Marco Cicardi, Prof.

Ospedale Luigi Sacco
Milan, Italy
  Connect »

Robert Brudevold, Dr.

Alesund Hospital
Alesund, Norway
  Connect »

Ellen Pritzier, Dr.

Stavanger University Hospital
Stavanger, Norway
  Connect »

Krystyna Obtulowicz, Prof.

University Hospital Krakow
Krakow, Poland
  Connect »

Katarina Hrubiskova, Dr.

Bratislava University Hospital
Bratislava, Slovakia
  Connect »

Milos Jesenak, Prof.

University Hospital Martin
Martin, Slovakia
  Connect »

Janne Bjorkander, Prof.

Ryhof County Hospital
Jonkoping, Sweden
  Connect »